(Q42705162)

5 November 2017

title

Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats (English)

1 reference

5 November 2017

Manar Hamed Arafa

1

1 reference

5 November 2017

Nanies Sameeh Mohammad

series ordinal

2

1 reference

5 November 2017

Hebatallah Husseini Atteia

series ordinal

3

1 reference

5 November 2017

Hesham Radwan Abd-Elaziz

series ordinal

4

1 reference

5 November 2017

publication date

18 June 2014

1 reference

Journal of Physiology and Biochemistry

5 November 2017

published in

1 reference

5 November 2017

volume

70

1 reference

5 November 2017

issue

3

1 reference

5 November 2017

page(s)

701-711

1 reference

Resveratrol enhances the cytotoxic profile of docetaxel and doxorubicin in solid tumour cell lines in vitro.

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Davallialactone protects against adriamycin-induced cardiotoxicity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol-associated renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Different effects of resveratrol on dose-related Doxorubicin-induced heart and liver toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol attenuates doxorubicin-induced cardiomyocyte apoptosis in lymphoma nude mice by heme oxygenase-1 induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Chemosensitization of tumors by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Extracellular superoxide dismutase regulates cardiac function and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

The triggering of apoptosis in macrophages by pristine graphene through the MAPK and TGF-beta signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Clinical trials of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: a potentially protective mechanism in atherosclerotic vascular disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol and health--a comprehensive review of human clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Heat shock proteins as emerging therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Dietary trans-resveratrol bioavailability and effect on CCl4-induced liver lipid peroxidation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Cellular and molecular effects of resveratrol in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13105-014-0339-Y

Cardioprotective effect of lipistat against doxorubicin induced myocardial toxicity in albino rats.

21 January 2018

1 reference

12 December 2020

Improved method for the determination of blood glutathione

1 reference

12 December 2020

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

12 December 2020

Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

1 reference

12 December 2020

Antioxidant and antiapoptotic effects of proanthocyanidin and ginkgo biloba extract against doxorubicin-induced cardiac injury in rats

1 reference

12 December 2020

Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo

1 reference

12 December 2020

The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen

1 reference

12 December 2020

Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment

1 reference

12 December 2020

Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells

1 reference

12 December 2020

The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

The effects of resveratrol on oxidant/antioxidant systems and their cofactors in rats

1 reference

12 December 2020

Effect of resveratrol on heart function of rats with adriamycin-induced heart failure

1 reference

12 December 2020

Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation.

1 reference

12 December 2020

Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway

1 reference

12 December 2020

10.1007/S13105-014-0339-Y

Identifiers

DOI

1 reference

5 November 2017

1 reference